TotalMarketCap

Adlai Nortye Group

ANLNasdaq Cayman IslandsHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$619.508 M

$9.62 +0.10%

Close of 6 Nov 2026

As of 6 Nov 2026, Adlai Nortye Group (ANL) has a market capitalization of $619.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #170Design TherapeuticsDSGN$624.4M
  2. #171Obsidian TherapeuticsOBX$620.2M
  3. #172Adlai Nortye GroupANL$619.5M
  4. #173Helus PharmaHELP$613.7M
  5. #174GeronGERN$612.0M

What if Adlai Nortye Group were worth as much as…

Open the what-if tool →

Gold $28.2T

$438,474.81

Per share 45,580× higher

Bitcoin $1.53T

$23,725.11

Per share 2,466× higher

Apple $5.02T

$77,887.32

Per share 8,096× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Adlai Nortye Group are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.